Heron Therapeutics, Inc. · NASDAQ:HRTX
Duarte Ira exercised options for 3,874 Heron Therapeutics, Inc. shares (Form 4)
Traded Apr 19, 2026 · Filed Apr 21, 2026
On Apr 19, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 3,874 Heron Therapeutics, Inc. shares, leaving 215,876 shares. Filed Apr 21, 2026 (Form 4).
- Options exercised
- 3,874 shares
- Holding after
- 215,876 shares
- Trading plan
- No
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 19, 2026 | Common Stock | Option exercise | 3,874 | 215,876 | Direct |
Source
Related
- Heron Therapeutics, Inc.
- Duarte Ira
- Heron Therapeutics, Inc. shareholders
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Duarte Ira · Aug 3, 2026
- Form 4 · Duarte Ira · Jul 20, 2026
- Form 4 · Duarte Ira · Jun 17, 2026
- Form 4 · Duarte Ira · May 4, 2026
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026
- Form 4 · Forbes William P · Aug 3, 2026